PERCEPTIC RAISES $12M FOR AI DRUG DEVELOPMENT

London-based Perceptic closed a $12 million seed round led by Accel to expand its end-to-end AI platform for pharmaceutical development. The startup was founded by three former Palantir executives who built Palantir's Life Sciences practice.